Viewing Study NCT05568095


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2025-12-29 @ 1:53 AM
Study NCT ID: NCT05568095
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-23
First Post: 2022-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
Sponsor: Arcus Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module